Feed aggregator

Old Linux Kernel flaw CVE-2024-1086 resurfaces in ransomware attacks  Security Affairs

Old Linux Kernel flaw CVE-2024-1086 resurfaces in ransomware attacks  Security Affairs

Old Linux Kernel flaw CVE-2024-1086 resurfaces in ransomware attacks  Security Affairs

Old Linux Kernel flaw CVE-2024-1086 resurfaces in ransomware attacks  Security Affairs

Old Linux Kernel flaw CVE-2024-1086 resurfaces in ransomware attacks  Security Affairs

Old Linux Kernel flaw CVE-2024-1086 resurfaces in ransomware attacks  Security Affairs

Old Linux Kernel flaw CVE-2024-1086 resurfaces in ransomware attacks  Security Affairs

Old Linux Kernel flaw CVE-2024-1086 resurfaces in ransomware attacks  Security Affairs

Old Linux Kernel flaw CVE-2024-1086 resurfaces in ransomware attacks  Security Affairs

An anonymous reader shares a report: The rush to secure electricity has intensified as tech companies look to spend trillions of dollars building data centers. There's an industry that consumes even more power than many tech giants, and it has largely escaped the same scrutiny: suppliers of industrial gases. Everyday items like toothpaste and life-saving treatments like MRIs are among the countless parts of modern life that hinge on access to gases such as nitrogen, oxygen and helium. Producing and transporting these gases to industrial facilities and hospitals is a highly energy-intensive process. Three companies -- Linde, Air Liquide and Air Products and Chemicals -- control 70% of the $120 billion global market for industrial gases. Their initiatives to rein in electricity use or switch to renewables aren't enough to rapidly cut carbon emissions, according to a new report from the campaign group Action Speaks Louder. "The scale of the sector's greenhouse gas emissions and electricity use is staggering," said George Harding-Rolls, the group's head of campaigns and one of the authors of the report. Linde's electricity use in 2024 exceeded that of Alphabet's Google and Samsung Electronics as well as oil giant TotalEnergies, while the power use of Air Liquide and Air Products was comparable to that of Shell and Microsoft. Yet unlike fossil fuel and tech companies, these industrial gas companies are far from household names because their customers are the world's largest chemicals, steel and oil companies rather than average consumers. The industry relies on air-separation units, which use giant compressors to turn air into liquid and then distill it into its many components. These machines are responsible for much of the industry's electricity demand, and their use alone is responsible for 2% of carbon dioxide emissions in China and the US, the world's two largest polluters.

Read more of this story at Slashdot.

Designing for reliability: How Nokia SR Linux and Event-Driven Automation transform data center network design  Nokia

Designing for reliability: How Nokia SR Linux and Event-Driven Automation transform data center network design  Nokia

Kodi 21.3 Improves Blu-Ray Playback on Linux, Adds HDR Support on Xbox One  9to5Linux

Kodi 21.3 Improves Blu-Ray Playback on Linux, Adds HDR Support on Xbox One  9to5Linux

Kodi 21.3 Improves Blu-Ray Playback on Linux, Adds HDR Support on Xbox One  9to5Linux

Kodi 21.3 Improves Blu-Ray Playback on Linux, Adds HDR Support on Xbox One  9to5Linux

Kodi 21.3 Improves Blu-Ray Playback on Linux, Adds HDR Support on Xbox One  9to5Linux

A top United States regulator plans to unveil a faster approach to approving custom gene-editing treatments, a move designed to unleash a wave of industry investment that will yield cures for patients with rare diseases. From a report: Vinay Prasad, who oversees gene therapies at the Food and Drug Administration, said scientific advances, like Crispr, have forced the agency to relax some of its strict rules. As an example, he cited the case of 10-month-old KJ Muldoon, who this year became the first person in history to have his genes custom edited to cure an inherited disease. "Regulation has to evolve as fast as science evolves," Prasad said in an interview with Bloomberg News. The agency is "going to be extremely flexible and work very fast with the scientists who want to bring these therapies to kids who need it." Prasad plans to publish a paper in early November outlining the FDA's new approach. He predicted it will spark interest in developing treatments for conditions that may affect only a handful of people.

Read more of this story at Slashdot.

Check out all of the photos captured on the latest Pixel series phones at the Mexico City celebration.

Check out all of the photos captured on the latest Pixel series phones at the Mexico City celebration.